Community-Based Communication Approaches for Blood Donation in Ghana

Status Completed

Clinical Trial Summary

DESIGN This pilot study utilizes a mixed-methods approach to develop a novel docu- drama communication strategy, design WhatsApp intervention, evaluate the feasibility of a larger pragmatic randomized controlled trial (RCT) of the two communication strategies and assess acceptability of the communication strategies aimed to increase blood donation among first-time blood donors within the catchment areas of the Southern Zonal Blood Centre (SZBC) in Ghana. In sequence, this pilot study and larger RCT are grounded in the PRECEDE-PROCEED implementation science framework. The pilot study has four components: 1) a qualitative component will be used to design a docu-drama, 2) key informant interviews to guide intervention development, 3) a simultaneous randomized pilot trial will evaluate the feasibility of the larger trial design of communication interventions using WhatsApp compared to control, and 4) a final mixed- methods (quantitative survey and focus groups) assessment of participant views of acceptability, effectiveness, feasibility and cultural appropriateness of the two proposed communication interventions. OBJECTIVES The three objectives of this pilot study are the careful design of a novel docu- drama communication intervention and WhatsApp intervention, evaluation of the feasibility of a larger RCT of communication strategies, and assessment of participant views of the two proposed communication interventions and control among first time blood donors within the catchment areas of the SZBC. For the purposes of registration for clinicaltrials.gov only the randomized pilot trial communication interventions using WhatsApp compared to control is reported. The planned sample size for the pilot RCT is n=128 first-time blood donors. The study population for the pilot RCT is first-time voluntary non-remunerated blood donors (VNRBD) and family/replacement blood donors (FRD) from the SZBC catchment area. REGIMEN WhatsApp: Participants assigned to the WhatsApp group will receive weekly messages developed by communication specialists aimed to motivate blood donation, be encouraged to discuss their blood donation experiences, and share their own motivations for donating blood in a moderated, closed group over a six-month duration. The moderator will provide guidelines on acceptable use of WhatsApp in the group, including images they can or cannot share. Participants will also receive standard NBSG communications for first-time donors. Control: Participants in this group will receive the standard NBSG communications for first-time donors: 1) a thank you phone call and 2) and a reminder phone call two-weeks prior to the second blood donation eligibility. The second blood donation eligibility is four months after the first donation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Blood Donors

Clinical Trial Details

NCT number	NCT04783077
Study type	Interventional
Source	University of Minnesota
Contact
Status	Completed
Phase	N/A
Start date	November 2, 2021
Completion date	September 25, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00097006` - Retrovirus Epidemiology Donor Study-II (REDS-II)	N/A
Completed	`NCT00005721` - Retaining Donors and Increasing Donation Frequency	N/A
Recruiting	`NCT04078893` - The Effect of Recruiting Inactive Blood Donors Using Different Means	N/A
Completed	`NCT02274064` - Motivating Type O- Blood Donors to Return	N/A
Completed	`NCT02717338` - Blood Donor Competence, Autonomy and Relatedness Enhancement	Phase 3
Completed	`NCT01104740` - Dengue Seroprevalence Study in Blood Donors in the French West Indies
Completed	`NCT03988738` - Promoting Repeat Blood Donation Through Social Media Among First-time Donors in a Peruvian Blood Bank	N/A
Completed	`NCT04088695` - Effect of a Web Page Based on a Motivational Video for Voluntary Blood Donation	N/A
Completed	`NCT00005278` - Retrovirus Epidemiology Donor Study I (REDS I)	N/A
Recruiting	`NCT00001846` - Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
Terminated	`NCT00005341` - Blood Donation--Immune Sequelae and Recruitment
Completed	`NCT00005339` - Risk of Post Transfusion Hepatitis C Virus Infection	N/A
Completed	`NCT03835299` - Addressing Fear and Risk of Vasovagal Reactions Among High School Donors	N/A
Recruiting	`NCT06021925` - Obstetrical History and Anti-HLA Antibodies Level
Completed	`NCT00005360` - HIV Diversity and Pathogenesis in Donor-Recipient Clusters	N/A
Completed	`NCT03102385` - A Survey of Attitudes of Experienced Blood Donors	N/A
Completed	`NCT02145507` - Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution	Phase 1
Completed	`NCT00029406` - Transfusion Infections Pediatric Prospective Study (TRIPPS)	N/A
Completed	`NCT00006310` - KSHV Infection in Blood Donors From Texas	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Community-Based Communication Approaches for Blood Donation in Ghana — C-CAD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms